BusinessCapricor to Present on Exosomes at the Plenary Session of the International Society for Cellular Therapy in MontrealBy Nasdaq OMXMay 3, 2018, 11:01 AM UTC
BusinessCapricor Announces Initiation of HOPE-2 Clinical Trial of CAP-1002 for Duchenne Muscular DystrophyBy Nasdaq OMXApr 30, 2018, 11:01 AM UTC
BusinessSummit Presents New 24-Week Analyses from PhaseOut DMD at the 2018 American Academy of Neurology Annual MeetingBy Nasdaq OMXApr 20, 2018, 11:00 AM UTC
BusinessSummit Completes Dosing of Ezutromid in PhaseOut DMD Clinical TrialBy Nasdaq OMXApr 19, 2018, 11:01 AM UTC
BusinessCapricor to Provide Presentation at the Alliance for Regenerative Medicine’s Investor DayBy Nasdaq OMXApr 12, 2018, 11:00 AM UTC
BusinessSummit Therapeutics Reports Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2018 and Operational ProgressBy Nasdaq OMXApr 11, 2018, 11:01 AM UTC
BusinessSummit Therapeutics Selected for Emerging Science Presentation at the 2018 American Academy of Neurology Annual MeetingBy Nasdaq OMXMar 28, 2018, 11:00 AM UTC
BusinessSummit Therapeutics Announces Placement of £15.0 Million of Ordinary SharesBy Nasdaq OMXMar 27, 2018, 11:01 AM UTC
